David Roy

Interventional cardiologist / Cardiologist
St Vincent's Hospital Sydney - Sydney, Australia

Latest contributions

Selection of the 2023 best clinical cases

19 Feb 2023 – From PCR Tokyo Valves 2023

Explore the most outstanding clinical cases from PCR Tokyo Valves 2023, including a delayed left ventricular rupture after transcatheter edge-to-edge mitral valve repair and successful bailouts in transcatheter mitral valve repair.

Remaining unmet needs and strategies in TAVI

19 Feb 2023 – From PCR Tokyo Valves 2023

This session focuses on valve design and durability performance in TAVI for patients with aortic stenosis, and the way it impacts future patient outcomes. 

Selection of the 2023 best abstracts

19 Feb 2023 – From PCR Tokyo Valves 2023

Watch this session to discover the best cases and abstracts unveiled at PCR Tokyo Valves 2023, covering topics such as transcatheter aortic valve implantation impact, cerebral protection efficacy, and post-TAVI aortic regurgitation quantification.

TAVI and difficult anatomy

18 Feb 2023 – From PCR Tokyo Valves 2023

Consult this session to discover how TAVI techniques helped cases of complex anatomy, such as: extremely horizontal aorta patient treated with snare-assisted TAVI technique, a novel simplified pacing-over-the-wire technique, successful non-contrast TAVI, and much more!

TAVI in a patient with heavily calcified valve anatomy - LIVE case

18 Feb 2023 – From PCR Tokyo Valves 2023

An 80-year-old male with chronic kidney disease and interstitial pneumonia treated under steroids presented a symptomatic severe aortic stenosis with massive calcifications on the valves and only on the valves (not the LVOT).
Watch the operators implant a Sapien 3 23 mm (-1cc) with a predilatation (Balloon...

TAVI in a patient with heavily calcified valve anatomy

TAVI in complex situations - LIVE case

28 Nov 2022 – From PCR London Valves 2022

  • Part 1: TAVI with the presence of a mechanical mitral valve.
    An 80-year-old female with a history of mechanical mitral valve (25 On-X in 2015) presents severe symptomatic AS with preserved LV function. The operators implant a 25 mm Navitor, with predilatation (18 mm balloon) on wire pacing...
Transcatheter intervention for aortic valve disease: state of the art

PCR TV: Valve selection considerations for the Heart Team

11 Oct 2021

Which valve for which patient? The question is no longer just whether to choose a balloon-expandable or a self-expanding valve: low-risk indications, increasing number of TAVI procedures, and growing complexity of patients are leading the TAVI community to become more prescriptive and to take time to...

Why durability matters: lifetime management considerations for supra-annular TAVR

26 Sep 2021 – From PCR Tokyo Valves 2021

In this session, the speakers address the problem of the evolution of clinical data for TAVI from extreme to low risk based on a number of studies on the subject, such as CoreValve Pivotal Study, Partner Study, SURTAVI Study, or Evolut Low-Risk Study, and then focus...

Why durability matters: lifetime management considerations for supra-annular TAVR